Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
about
Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@en
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@nl
type
label
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@en
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@nl
prefLabel
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@en
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@nl
P2093
P2860
P1476
Ivabradine and metoprolol diff ...... a mouse model of dyslipidemia.
@en
P2093
Christine Des Rosiers
Dominic Lachance
Fanny Vaillant
Jean-Claude Tardif
Marie-Eve Rivard
Matthieu Ruiz
Virginie Bolduc
Yanfen Shi
P2860
P304
H991-H1003
P356
10.1152/AJPHEART.00789.2015
P577
2016-08-05T00:00:00Z